ISRCTN86618747
Completed
Not Applicable
A randomised double-blind placebo controlled study of adenosine given as a Bier's block for patients with neuropathic pain in the limbs
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 sites30 target enrollmentSeptember 12, 2003
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Signs and Symptoms: Pain
- Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Not provided at time of registration
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A randomised double-blind placebo-controlled study of energy, protein and micronutrients supplementation of elderly patients in active rehabilitation settingsutritional status in the elderlyNutritional, Metabolic, EndocrineNutritional statusISRCTN01133608The Health Foundation (UK)445
Completed
Not Applicable
A randomised double-blind placebo-controlled study to investigate the possible role of Opiate Morphine (MST) in the treatment of chronic cough.ISRCTN18474014Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)30
Completed
Phase 3
A randomised double-blind placebo-controlled study to evaluate the effect ofcurcumin on BDNF levels in otherwise healthy adults.Brain-Derived Neurotrophic Factor in healthy adultsNeurological - Studies of the normal brain and nervous systemAlternative and Complementary Medicine - Other alternative and complementary medicineACTRN12621000104853RDC Global Pty Ltd69
Completed
Not Applicable
A randomised double blind placebo controlled study to evaluate the effectiveness of purified d-Limonene as an agent to relieve the symptoms of indigestion and heartburGastrointestinal discomfort (indigestion/heartburn)Digestive SystemGastrointestinal discomfortISRCTN96109983WRC Laboratories LP (USA)50
Completed
Phase 3
isdexamfetamine for the treatment of methamphetamine addictioAddictionMethamphetamine dependenceMental Health - AddictionACTRN12617000657325niversity of New South Wales155